Form 8-K - Current report:
SEC Accession No. 0001193125-25-032114
Filing Date
2025-02-21
Accepted
2025-02-21 17:28:04
Documents
16
Period of Report
2025-02-21
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d868928d8k.htm   iXBRL 8-K 30491
2 EX-10.1 d868928dex101.htm EX-10.1 80195
3 EX-99.1 d868928dex991.htm EX-99.1 11346
7 GRAPHIC g868928g0222030424163.jpg GRAPHIC 1716
  Complete submission text file 0001193125-25-032114.txt   272007

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA ftre-20250221.xsd EX-101.SCH 2838
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE ftre-20250221_lab.xml EX-101.LAB 17235
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ftre-20250221_pre.xml EX-101.PRE 10804
18 EXTRACTED XBRL INSTANCE DOCUMENT d868928d8k_htm.xml XML 3479
Mailing Address 8 MOORE DRIVE DURHAM NC 27709
Business Address 8 MOORE DRIVE DURHAM NC 27709 877-495-0816
Fortrea Holdings Inc. (Filer) CIK: 0001965040 (see all company filings)

EIN.: 922796441 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41704 | Film No.: 25653350
SIC: 8071 Services-Medical Laboratories
(CF Office: 08 Industrial Applications and Services)